STOCKHOLM, Sweden, Nov. 8, 2004 (PRIMEZONE) -- Artimplant AB, a Swedish biomaterials and orthobiologics company, has been granted CE-certification for a thicker and stronger -- size 2 -- Artelon(R) Surgical Suture that meets additional needs mainly in orthopedics. Previously, a thinner size -- 2-0 -- suture has been approved for marketing in Europe.
Artelon(R), a degradable polyurethaneurea, is a unique patented biomaterial that acts as a temporary support to the healing tissue. Excellent biocompatibility for Artelon(R) is demonstrated at several time intervals in soft tissue and bone. The long degradation time of Artelon surgical suture offers benefits to patients, especially in situations with slow healing or in tissue exposed to high mechanical load, for example repair of tendon and ligaments.
The new suture is suitable for repair of tendons and ligaments, e.g. Achilles tendon.
Artimplant intends to further expand its product line of fibers, scaffolds and films for use in various orthopedic, oral and plastic surgery applications.
For additional information, please contact: Tord Lendau, CEO, phone +46 (0)31 746 56 00, +46 (0)708 369 403, tord.lendau@artimplant.se www.artimplant.com
Artimplant's mission is to develop novel biodegradable materials and implants that meet the needs of patients, physicians and healthcare providers in orthopedics and other therapy areas. The company works together with global partners as a center of excellence in this development.
Artimplant's vision is to become the partner of choice in biomaterials for hard and soft tissue repair in multiple therapy areas. Artimplant is a public company, listed on the Stockholm Exchange, O-list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download: http://www.waymaker.net/bitonline/2004/11/08/20041108BIT21210/wkr0001.pdf
-0-